Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
2minutemedicine.com
19h
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma
Afami-cel (Tecelra) is the first genetically engineered T-cell receptor therapy for synovial sarcoma Afami-cel demonstrated ...
2minutemedicine.com
21h
Semaglutide reduces heart failure events in patients with preserved ejection fraction
Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene now hurricane
Workers lose arbitration
Would-be assassin charged
Gets 2-yrs for role in fraud
Penn suspends law professor
Campaign office damaged
KY sheriff pleads not guilty
Woman dies in 'suicide pod’
Study: Myopia on the rise
To cut Atlanta service, jobs
Dog food recalled
Chemical leak in OH county
CA new gun control laws
New home sales fall
New COVID, flu shots
US to waive visas for Qatar
Calls strike against 'LoL’
Israel intercepts first missile
NYC schools boss retiring
Pac-12 sues Mountain West
Briefed on Iranian threats
First transparency report
School book bans surge
Texas AG appeal denied
Fat Bear Week coming up
Exec apologizes for outage
Shippers seek workarounds
China conducts ICBM test
WA abortion pill stockpile
Senate report details lapses
Feedback